Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis


Creative Commons License

Dhami S., Nurmatov U., Arasi S., Khan T., Asaria M., Zaman H., ...More

ALLERGY, vol.72, no.11, pp.1597-1631, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 72 Issue: 11
  • Publication Date: 2017
  • Doi Number: 10.1111/all.13201
  • Journal Name: ALLERGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1597-1631
  • Keywords: allergen, allergen immunotherapy, allergic rhinoconjunctivitis, subcutaneous, sublingual, PLACEBO-CONTROLLED TRIAL, HOUSE-DUST-MITE, SUBLINGUAL-SWALLOW IMMUNOTHERAPY, POLLEN-INDUCED RHINOCONJUNCTIVITIS, RANDOMIZED CONTROLLED-TRIAL, SHORT-TERM IMMUNOTHERAPY, STANDARDIZED 5-GRASS-POLLEN EXTRACT, COST-EFFECTIVENESS ANALYSIS, MONOPHOSPHORYL-LIPID-A, SUMMER HAY-FEVER
  • Open Archive Collection: AVESIS Open Access Collection
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

BackgroundThe European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing Guidelines on Allergen Immunotherapy (AIT) for Allergic Rhinoconjunctivitis. To inform the development of clinical recommendations, we undertook a systematic review to assess the effectiveness, cost-effectiveness, and safety of AIT in the management of allergic rhinoconjunctivitis.